BTC$75,922.32▼ 5.97%ETH$2,235.36▼ 8.15%USDT$0.9989▼ 0.04%BNB$693.47▼ 3.23%XRP$1.21▼ 8.09%USDC$1.00▼ 0.02%SOL$89.87▼ 7.14%TRX$0.3187▼ 0.36%FIGR_HELOC$1.04▼ 1.02%ZEC$1,283.88▼ 2.30%HYPE$77.16▼ 8.00%XMR$118.70▼ 2.33%DOGE$0.0718▼ 7.22%USDS$1.00▼ 0.00%WBT$72.94▼ 6.60%LEO$9.35▼ 0.06%LINK$10.86▼ 6.52%ADA$0.1839▼ 7.62%BCH$275.40▼ 2.47%XLM$0.1548▼ 8.13%NEAR$3.68▼ 9.12%USDE$1.00▼ 0.07%DAI$1.00▼ 0.02%RAIN$0.006100▲ 2.00%UNI$6.97▼ 10.66%LTC$52.42▼ 7.05%CC$0.0970▼ 4.93%AVAX$8.27▼ 6.07%USD1$0.9992▼ 0.08%SUI$0.8588▼ 8.07%XAUT$4,032.64▼ 2.17%GRAM$1.10▼ 5.05%HBAR$0.0684▼ 6.77%USDG$1.00▲ 0.00%QNT$189.60▼ 8.33%SHIB$0.000005▼ 3.81%PYUSD$1.00▲ 0.00%RLUSD$1.00▲ 0.03%TAO$219.40▼ 7.47%CRO$0.0492▼ 6.13%BTC$75,922.32▼ 5.97%ETH$2,235.36▼ 8.15%USDT$0.9989▼ 0.04%BNB$693.47▼ 3.23%XRP$1.21▼ 8.09%USDC$1.00▼ 0.02%SOL$89.87▼ 7.14%TRX$0.3187▼ 0.36%FIGR_HELOC$1.04▼ 1.02%ZEC$1,283.88▼ 2.30%HYPE$77.16▼ 8.00%XMR$118.70▼ 2.33%DOGE$0.0718▼ 7.22%USDS$1.00▼ 0.00%WBT$72.94▼ 6.60%LEO$9.35▼ 0.06%LINK$10.86▼ 6.52%ADA$0.1839▼ 7.62%BCH$275.40▼ 2.47%XLM$0.1548▼ 8.13%NEAR$3.68▼ 9.12%USDE$1.00▼ 0.07%DAI$1.00▼ 0.02%RAIN$0.006100▲ 2.00%UNI$6.97▼ 10.66%LTC$52.42▼ 7.05%CC$0.0970▼ 4.93%AVAX$8.27▼ 6.07%USD1$0.9992▼ 0.08%SUI$0.8588▼ 8.07%XAUT$4,032.64▼ 2.17%GRAM$1.10▼ 5.05%HBAR$0.0684▼ 6.77%USDG$1.00▲ 0.00%QNT$189.60▼ 8.33%SHIB$0.000005▼ 3.81%PYUSD$1.00▲ 0.00%RLUSD$1.00▲ 0.03%TAO$219.40▼ 7.47%CRO$0.0492▼ 6.13%

Muhdo Hub vs Pieverse

Pieverse (PIEVERSE) is 17457.0× the size of Muhdo Hub (DNA) by market capitalisation. PIEVERSE has been the more volatile of the two, at 143% annualised against DNA's 97%.

Size ratio
1 : 17457.0
Muhdo HubDNA

$4.590e-6

24h
—
Market cap
$19,862
Volume 24h
—
Volatility (ann.)
97%
PieversePIEVERSE

$1.2600

24h
+5.34%
Market cap
$346.73M
Volume 24h
$15.10M
Volatility (ann.)
143%
DNA 0.0%Share of the two combined market caps100.0% PIEVERSE

Performance

DNAPIEVERSE

  1. 7 days-11.57%+27.18%PIEVERSE
  2. 30 days—+7.83%—

Risk & extremes

MetricDNAPIEVERSE
Max drawdown (400d)-16.8%-38.7%
Risk-adjusted return (90d)-0.060.32

Relative strength over 90 days: DNA outperformed PIEVERSE by 9.6% — measured on the DNA/PIEVERSE ratio, so it holds regardless of market direction.